What is Siyan Clinical?
Siyan Clinical Corporation stands as a premier provider of outpatient psychiatric care, maintaining a dominant market position within Sonoma and Marin counties. By integrating advanced therapeutic modalities such as Transcranial Magnetic Stimulation (TMS) and SPRAVATO® alongside structured Intensive Outpatient Programs (IOP), the company addresses critical gaps in mental health infrastructure. Their commitment to high-quality, compassionate care in modern clinical settings has established them as a cornerstone of the regional healthcare ecosystem, effectively bridging the divide between traditional psychiatric practice and innovative, evidence-based intervention strategies.
How much funding has Siyan Clinical raised?
Siyan Clinical has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Siyan Clinical
PPP
Public-Private Partnership
What's next for Siyan Clinical?
The infusion of capital positions Siyan Clinical to accelerate its growth strategy, likely focusing on the expansion of its physical footprint and the enhancement of its digital health capabilities. As the organization transitions through this late-stage funding phase, the focus will shift toward operational efficiency and the potential for regional consolidation. By leveraging this financial backing, Siyan Clinical is well-equipped to meet the rising demand for specialized mental health services, ensuring that its clinical protocols remain at the forefront of psychiatric medicine while maintaining the high standards of patient care that define its brand identity.
See full Siyan Clinical company page
